Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

UNITED THERAPEUTICS (UTHR) Enterprise Value: 2009-2024

Historic Enterprise Value for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Dec 2024 value amounting to $12.5 billion.

  • UNITED THERAPEUTICS's Enterprise Value rose 28.33% to $16.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.6 billion, marking a year-over-year increase of 66.21%. This contributed to the annual value of $12.5 billion for FY2024, which is 70.12% up from last year.
  • UNITED THERAPEUTICS's Enterprise Value amounted to $12.5 billion in FY2024, which was up 70.12% from $7.3 billion recorded in FY2023.
  • In the past 5 years, UNITED THERAPEUTICS's Enterprise Value ranged from a high of $12.5 billion in FY2024 and a low of $4.9 billion during FY2020.
  • For the 3-year period, UNITED THERAPEUTICS's Enterprise Value averaged around $9.9 billion, with its median value being $9.8 billion (2022).
  • Per our database at Business Quant, UNITED THERAPEUTICS's Enterprise Value skyrocketed by 106.40% in 2020 and then dropped by 25.38% in 2023.
  • Over the past 5 years, UNITED THERAPEUTICS's Enterprise Value (Yearly) stood at $4.9 billion in 2020, then soared by 58.86% to $7.8 billion in 2021, then rose by 26.09% to $9.8 billion in 2022, then declined by 25.38% to $7.3 billion in 2023, then spiked by 70.12% to $12.5 billion in 2024.